Prostacor, 5 mg/ml 1 ml 10 pcs

Promotes reduction of edema, leukocytic infiltration and thrombosis of prostate venules, normalizes secretory function of epithelial cells, increases the number of lecithin grains in the secretion of acini, stimulates muscle tone of the bladder.

Indications

Chronic prostatitis; complications after prostate surgery.

Pharmacological effect

Helps reduce edema, leukocyte infiltration and thrombosis of prostate venules, normalizes the secretory function of epithelial cells, increases the number of lecithin grains in the acini secretion, and stimulates the muscle tone of the bladder.

Special instructions

Maltose contained in Prostacor® may affect blood and urine glucose levels when determined in the laboratory.

Active ingredient

Prostate extract

Composition

1 ampoule contains as

Contraindications

Hypersensitivity

Children and teenagers under 18 years of age.

Side Effects

Allergic reactions.

Interaction

No clinically significant consequences of interaction of the drug Prostacor® with other drugs have been identified.

Overdose

Cases of overdose of Prostacor® have not been described.

Storage conditions

In a dry place, protected from light, at a temperature of 2–8 °C

Shelf life

2 years

Manufacturer

Microgen NPO, Russia